Literature DB >> 36074295

CircEXOC5 facilitates cell pyroptosis via epigenetic suppression of Nrf2 in septic acute lung injury.

Wei Wang1,2, Yuqing Xiong3, Haomiao Zhao3, Rongli Xu4.   

Abstract

Acute lung injury (ALI) caused by sepsis is characterized by a destructive high inflammatory response in lungs, which is the ultimate cause of high mortality to patients diagnosed with sepsis. The objective of the present study is to explore the effect and related mechanisms of circEXOC5 on pyroptosis in septic ALI. Sepsis ALI mouse model was induced and established by CLP induction and sepsis MPVEC cell model by LPS. HE staining was used to detect lung tissue pathological changes. ELISA, flow cytometry, and Western blot were utilized to evaluate the release of inflammatory cytokines and cell pyroptosis, and RIP was applied to verify the binding relationship between EZH2 and circEXOC5 or Nrf2. Finally, the interaction between CircEXOC5 and EZH2, H3k27me3, and Nrf2 promoter regions was clarified using ChIP. CircEXOC5 levels were notably ascended in the lung tissues of septic ALI mice. And silencing circEXOC5 inhibited cell pyroptosis and the release of inflammatory cytokines in MPVEC stimulated by LPS. In addition, RIP and ChIP indicated that Nrf2 expression in MPVECs cells could be inhibited by circEXOC5 via recruiting EZH2. In addition, ML385 (a specific inhibitor of Nrf2) reversed the efficacy of Knockdown of circEXOC5 on the Inhibition of pyroptosis and inflammation of MPVEC cells stimulated by LPS. These results indicated that CircEXOC5 could promote cell pyroptosis through epigenetic inhibition of Nrf2 in septic ALI.
© 2022. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  ALI; Cell pyroptosis; CircEXOC5; Nrf2; Sepsis

Year:  2022        PMID: 36074295     DOI: 10.1007/s11010-022-04521-1

Source DB:  PubMed          Journal:  Mol Cell Biochem        ISSN: 0300-8177            Impact factor:   3.842


  29 in total

Review 1.  The role of apoptosis in acute lung injury.

Authors:  Thomas R Martin; Morio Nakamura; Gustavo Matute-Bello
Journal:  Crit Care Med       Date:  2003-04       Impact factor: 7.598

Review 2.  Acute lung injury: epidemiology, pathogenesis, and treatment.

Authors:  Elizabeth R Johnson; Michael A Matthay
Journal:  J Aerosol Med Pulm Drug Deliv       Date:  2010-08       Impact factor: 2.849

3.  The Third International Consensus Definitions for Sepsis and Septic Shock (Sepsis-3).

Authors:  Mervyn Singer; Clifford S Deutschman; Christopher Warren Seymour; Manu Shankar-Hari; Djillali Annane; Michael Bauer; Rinaldo Bellomo; Gordon R Bernard; Jean-Daniel Chiche; Craig M Coopersmith; Richard S Hotchkiss; Mitchell M Levy; John C Marshall; Greg S Martin; Steven M Opal; Gordon D Rubenfeld; Tom van der Poll; Jean-Louis Vincent; Derek C Angus
Journal:  JAMA       Date:  2016-02-23       Impact factor: 56.272

Review 4.  The utility of clinical predictors of acute lung injury: towards prevention and earlier recognition.

Authors:  Joseph E Levitt; Michael A Matthay
Journal:  Expert Rev Respir Med       Date:  2010-12       Impact factor: 3.772

5.  Lower tidal volume ventilation and plasma cytokine markers of inflammation in patients with acute lung injury.

Authors:  Polly E Parsons; Mark D Eisner; B Taylor Thompson; Michael A Matthay; Marek Ancukiewicz; Gordon R Bernard; Arthur P Wheeler
Journal:  Crit Care Med       Date:  2005-01       Impact factor: 7.598

6.  Dihydromyricetin inhibits NLRP3 inflammasome-dependent pyroptosis by activating the Nrf2 signaling pathway in vascular endothelial cells.

Authors:  Qin Hu; Ting Zhang; Long Yi; Xi Zhou; Mantian Mi
Journal:  Biofactors       Date:  2017-11-29       Impact factor: 6.113

Review 7.  Heme oxygenase-1 as a target for drug discovery.

Authors:  Roberto Motterlini; Roberta Foresti
Journal:  Antioxid Redox Signal       Date:  2014-02-28       Impact factor: 8.401

8.  Mortality in sepsis versus non-sepsis induced acute lung injury.

Authors:  Jonathan E Sevransky; Gregory S Martin; Carl Shanholtz; Pedro A Mendez-Tellez; Peter Pronovost; Roy Brower; Dale M Needham
Journal:  Crit Care       Date:  2009-09-16       Impact factor: 9.097

9.  Interferon Regulatory Factor-1 Mediates Alveolar Macrophage Pyroptosis During LPS-Induced Acute Lung Injury in Mice.

Authors:  Dongdong Wu; Pinhua Pan; Xiaoli Su; Lemeng Zhang; Qingwu Qin; Hongyi Tan; Li Huang; Yuanyuan Li
Journal:  Shock       Date:  2016-09       Impact factor: 3.454

10.  Hemorrhagic shock primes for lung vascular endothelial cell pyroptosis: role in pulmonary inflammation following LPS.

Authors:  Jie Yang; Yanfeng Zhao; Peng Zhang; Yuehua Li; Yong Yang; Yang Yang; Junjie Zhu; Xiao Song; Gening Jiang; Jie Fan
Journal:  Cell Death Dis       Date:  2016-09-08       Impact factor: 8.469

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.